FDA to Convene Pharmacy Compounding Advisory Committee in July BPC 157 & TB 500 Peptide Therapy for Injury Recovery Sanctuary Wellness The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Announces Change in Status of 12 Peptides SSRP Institute